王羽雄｜复旦大学｜学者主页

2023

Key events in cancer: Dysregulation of SREBPs

Yun-Kuo Li, Shouwang Wu, Xiaodong Zhao, Shiming Hao, Fa-Ping Li, Yuxiong Wang, Bin Liu, Di-Di Zhang, Yi-Shu Wang, Hongmei Zhou

Frontiers in Pharmacology

DOI

2023

Role of extracellular vesicles in pathogenesis and therapy of renal ischemia-reperfusion injury.

Xi Chen, Yun-Kuo Li, Shouwang Wu, Yuxiong Wang, Bin Liu, Hong-Lan Zhou, Fa-Ping Li

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

DOI

2023

Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis

Yuxiong Wang, Yi-Shu Wang, Bin Liu, Xin Gao, Yun-Kuo Li, Fa-Ping Li, Hong-Lan Zhou

Frontiers in Genetics

DOI

2022

NLRP3 inflammasome: A potential therapeutic target to minimize renal ischemia/reperfusion injury during transplantation.

X. Su, Bin Liu, Shan Wang, Yuxiong Wang, Zehua Zhang, Hong-Lan Zhou, Fa-Ping Li

Transplant Immunology

DOI

2022

The role of MEOX1 in non-neoplastic and neoplastic diseases.

Guoqiang Zeng, Xiaojie Liu, X. Su, Yuxiong Wang, Bin Liu, Hong-Lan Zhou, Yuan-Tao Wang, Fa-Ping Li

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

DOI

2021

Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p/PCLAF axis

L. Pan, J. Sha, Wenyao Lin, Yuxiong Wang, Tingzhang Bian, Jian-Ming Guo

Experimental and Therapeutic Medicine

DOI

2021

Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy

Qingyun Yuan, Qiaoyan Liang, Zu-Jun Sun, Xingxing Yuan, W. Hou, Yuxiong Wang, Hui-Jie Wang, Min Yu

Oncoimmunology

DOI

2020

Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors

Xingxing Yuan, Zu-Jun Sun, Qingyun Yuan, W. Hou, Qiaoyan Liang, Yuxiong Wang, W. Mo, Hui-Jie Wang, Min Yu

Investigational new drugs

DOI

2020

Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review

Yuxiong Wang, Yuan-Tao Wang, Mingliang Feng, Xin Lian, Yongsheng Lei, Hong-Lan Zhou

Journal of International Medical Research

DOI

2019

Bromodomain-containing protein 2 promotes lipolysis via ERK/HSL signalling pathway in white adipose tissue of mice.

Jiu-Yu Zong, Shuting Li, Yuxiong Wang, W. Mo, R. Sun, Min Yu

General and Comparative Endocrinology

DOI

2018

A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer

W. Hou, Qingyun Yuan, Xingxing Yuan, Yuxiong Wang, W. Mo, Hui-Jie Wang, Min Yu

Investigational new drugs

DOI

2018

miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells.

Yuxiong Wang, H. Qin

American Journal of Cancer Research

2017

A novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer

Zu-Jun Sun, Yi Wu, W. Hou, Yuxiong Wang, Qingyun Yuan, Hui-Jie Wang, Min Yu

OncoTarget

DOI

2017

Bromodomain-containing protein 2 induces insulin resistance via the mTOR/Akt signaling pathway and an inflammatory response in adipose tissue.

R. Sun, Yi Wu, W. Hou, Zu-Jun Sun, Yuxiong Wang, Huanhuan Wei, W. Mo, Min Yu

Cellular Signalling

DOI

2017

Generation and Characterization of a Bispecific Antibody Targeting Both PD-1 and c-MET.

Yi Wu, Min Yu, Zu-Jun Sun, W. Hou, Yuxiong Wang, Qingyun Yuan, W. Mo

Protein Peptide Letters

DOI

2017

Characterization and high‐yield production of non‐N‐glycosylated recombinant human BCMA‐Fc in Pichia pastoris

W. Hou, Xianchao Meng, Yuxiong Wang, W. Mo, Yi Wu, Min Yu

Engineering in Life Sciences

DOI

2015

DNA methylation regulates bromodomain-containing protein 2 expression during adipocyte differentiation

R. Sun, Yi Wu, Yuxiong Wang, Kun Zang, Huanhuan Wei, Fangnian Wang, Min Yu

Molecular and Cellular Biochemistry

DOI

2013

Brd2 Inhibits Adipogenesis via the ERK1/2 Signaling Pathway in 3T3-L1 Adipocytes

Kun Zang, Jingyu Wang, Miao-Fang Dong, R. Sun, Yuxiong Wang, Yinong Huang, Xiao-Xia Liu, Yi-Min Li, Fangnian Wang, Min Yu

PLoS ONE

DOI

2012

Shp2 Activates Fyn and Ras to Regulate RBL-2H3 Mast Cell Activation following FcεRI Aggregation

Xiaoyun Fang, Yongjiang Lang, Yuxiong Wang, W. Mo, Huanhuan Wei, Jianhui Xie, Min Yu

PLoS ONE

DOI

2012

Expression and characterization of a variant of TACI (CRD2-shortTACIFc) in Pichia pastoris.

Rui Wang, Shi-Liang Zhou, Xiao-Dong Peng, Xin-Wen Zhou, Zhiqun Xie, Yuxiong Wang, W. Mo, Min Yu

Protein Peptide Letters

DOI

2011

Transient expression and biological activity identification of human pigment epithelium-derived factor in mammary cell line SP2/0

Y. Dai, Wen-jing Shi, Yuxiong Wang, Min Yu, Chao Chen

DOI

2009

人源性组织因子在SP2/0细胞中的初步表达

王羽雄，马春姑，顾银良，宋后燕，于敏

《药物生物技术》

2009

Expression and purification of APRIL by auto-induction.

Sanjian Yu, Yuxiong Wang, Yushan Liu, W. Mo, Hou-Yan Song, Min Yu

Protein Expression and Purification

DOI

2008

人组织因子在毕赤酵母中的表达和纯化

王羽雄，于敏，顾银良，宋后燕

《复旦学报(医学版)》

2002

可溶性组织因子的基因克隆、表达与性质研究

于敏，王羽雄，顾银良，宋后燕

《药物生物技术》

2002

可溶性组织因子突变体的基因构建、表达和性质

于敏，张宇杲，王羽雄，宋后燕

Acta Biochimica et Biophysica Sinica

2001

Recombination soluble tissue factor and preparation method and opplication thereof

Hou-Yan Song, Min Yu, Yuxiong Wang

王羽雄

精选作品

期刊论文

Key events in cancer: Dysregulation of SREBPs

Role of extracellular vesicles in pathogenesis and therapy of renal ischemia-reperfusion injury.

Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis

NLRP3 inflammasome: A potential therapeutic target to minimize renal ischemia/reperfusion injury during transplantation.

The role of MEOX1 in non-neoplastic and neoplastic diseases.

Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p/PCLAF axis

Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy

Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors

Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review

Bromodomain-containing protein 2 promotes lipolysis via ERK/HSL signalling pathway in white adipose tissue of mice.

A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer

miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells.

A novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer

Bromodomain-containing protein 2 induces insulin resistance via the mTOR/Akt signaling pathway and an inflammatory response in adipose tissue.

Generation and Characterization of a Bispecific Antibody Targeting Both PD-1 and c-MET.

Characterization and high‐yield production of non‐N‐glycosylated recombinant human BCMA‐Fc in Pichia pastoris

DNA methylation regulates bromodomain-containing protein 2 expression during adipocyte differentiation

Brd2 Inhibits Adipogenesis via the ERK1/2 Signaling Pathway in 3T3-L1 Adipocytes

Shp2 Activates Fyn and Ras to Regulate RBL-2H3 Mast Cell Activation following FcεRI Aggregation

Expression and characterization of a variant of TACI (CRD2-shortTACIFc) in Pichia pastoris.

Transient expression and biological activity identification of human pigment epithelium-derived factor in mammary cell line SP2/0

人源性组织因子在SP2/0细胞中的初步表达

Expression and purification of APRIL by auto-induction.

人组织因子在毕赤酵母中的表达和纯化

可溶性组织因子的基因克隆、表达与性质研究

可溶性组织因子突变体的基因构建、表达和性质

Recombination soluble tissue factor and preparation method and opplication thereof